Screening approaches for genetic toxicity

Predictive Toxicology in Drug Safety

Volumn , Issue , 2010, Pages 18-33

  Aubrecht, Jiri ^a   Xu, Jinghai J ^b  

^a PFIZER INC   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927061272     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511779053.004     Document Type: Chapter

References (65)

1. Kirkland D, Aardema M, Henderson L, et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: I. Sensitivity, specificity and relative predictivity. Mutat Res. 2005;584(l-2):l-256.
2. Kirkland D, Aardema M, Muller L, et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat Res. 2006;608(1):29-42.
3. Jacobs A, Jacobson-Kram D. Human carcinogenic risk evaluation, Part III: Assessing cancer hazard and risk in human drug development. Toxicol Sci. 2004;81(2):260-262.
4. Muller L, Kikuchi Y, Probst G, et al. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutat Res. 1999;436(3): 195-225.
5. Thybaud V, Aardema M, Clements J, et al. Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing. Mutat Res. 2007;627(1):41-58.
6. Aubrecht J, Caba E. Gene expression profile analysis: An emerging approach to investigate mechanisms of genotoxicity. Pharmacogenomics. 2005;6(4):419-428.
7. Ames BN, Durston WE, Yamasaki E, et al. Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA. 1973;70(8):2281-2285.
8. Muller A, Boitier E, Hu T, et al. Laboratory variability does not preclude identification of biological functions impacted by hydroxyurea. Environ Mol Mutagen. 2005;46(4):221-235.
9. Houk VS, Schalkowsky S, Claxton LD. Development and validation of the spiral Salmonella assay: An automated approach to bacterial mutagenicity testing. Mutat Res. 1989;223(1):49-64.
10. Rexroat MA, Oberly TJ, Bewsey BJ, et al. The gradient plate assay: A modified Ames assay used as a prescreen for the identification of bacterial mutagens. Mutat Res. 1995;341(3):185-192.
11. Brooks TM. The use of a streamlined bacterial mutagenicity assay, the MINISCREEN. Mutagenesis. 1995;10(5):447-448.
12. Falck K, Partanen P, Sorsa M, et al. Mutascreen, an automated bacterial mutagenicity assay. Mutat Res. 1985;150(1-2):119-125.
13. Gee P, Maron DM, Ames BN. Detection and classification of mutagens: A set of base-specific Salmonella tester strains. Proc Natl Acad Sci USA. 1994;91(24):11606-11610.
14. Ulitzur S. Bioluminescence test for genotoxic agents. Methods Enzymol. 1986;133:264-274.
15. Sun TS, Stahr HM. Evaluation and application of a bioluminescent bacterial genotox-icity test. J AOAC Int. 1993;76(4):893-898.
16. Cote C, Blaise C, Delisle CE, et al. A miniaturized Ames mutagenicity assay employing bioluminescent strains of Salmonella typhimurium. Mutat Res. 1995;345(3-4): 137-146.
17. Cariello NF, Narayanan S, Kwanyuen P, et al. A novel bacterial reversion and forward mutation assay based on green fluorescent protein. Mutat Res. 1998; 414(1-3):95-105.
18. Aubrecht J, Osowski JJ, Persaud P, et al. Bioluminescent Salmonella reverse mutation assay: A screen for detecting mutagenicity with high throughput attributes. Mutagenesis. 2007;22(5):335-342.
19. Ackerman J, Sharma R, Hitchcock J, et al. Inter-laboratory evaluation of the bioluminescent Salmonella reverse mutation assay using 10 model chemicals. Mutagenesis. 2009;24(5):433-438.
20. Parry EM, Parry JM, Corso C, et al. Detection and characterization of mechanisms of action of aneugenic chemicals. Mutagenesis. 2002; 17(6):509-521.
21. Bryce SM, Bemis JC, Avlasevich SL, et al. In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity. Mutat Res. 2007;630(1-2):78-91.
22. Frieauff W, Potter-Locher F, Cordier A, et al. Automatic analysis of the in vitro micronucleus test on V79 cells. Mutat Res. 1998;413(1):57-68.
23. Smolewski P, Ruan Q, Vellon L, et al. Micronuclei assay by laser scanning cytometry. Cytometry. 2001;45(1):19-26.
24. Decordier I, Papine A, Plas G, et al. Automated image analysis of cytokinesis-blocked micronuclei: An adapted protocol and a validated scoring procedure for biomonitoring. Mutagenesis. 2009;24(1):85-93.
25. Diaz D, Scott A, Carmichael P, et al. Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. Mutat Res. 2007;630(1-2):1-13.
26. Varga D, Johannes T, Jainta S, et al. An automated scoring procedure for the micronucleus test by image analysis. Mutagenesis. 2004;19(5):391-397.
27. Bryce SM, Avlasevich SL, Bemis JC, et al. Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assay. Mutat Res. 2008;650(2): 181-195.
28. Avlasevich SL, Bryce SM, Cairns SE, et al. In vitro micronucleus scoring by flow cytometry: Differential staining of micronuclei versus apoptotic and necrotic chromatin enhances assay reliability. Environ Mol Mutagen. 2006;47(l):56-66.
29. Hartmann A, Schumacher M, Plappert-Helbig U, et al. Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations. Mutagenesis. 2004;19(1): 51-59.
30. Kiskinis E, Suter W, Hartmann A. High throughput Comet assay using 96-well plates. Mutagenesis. 2002;17(1):37-43.
31. Schiestl RH. Nonmutagenic carcinogens induce intrachromosomal recombination in yeast. Nature. 1989;337(6204):285-288.
32. Carls N, Schiestl RH. Evaluation of the yeast DEL assay with 10 compounds selected by the International Program on Chemical Safety for the evaluation of short-term tests for carcinogens. Mutat Res. 1994;320(4):293-303.
33. Galli A, Schiestl RH. Effects of DNA double-strand and single-strand breaks on intrachromosomal recombination events in cell-cycle-arrested yeast cells. Genetics. Jul 1998;149(3):1235-1250.
34. Galli A, Schiestl RH. Hydroxyurea induces recombination in dividing but not in G1 or G2 cell cycle arrested yeast cells. Mutat Res. 1996;354(1):69-75.
35. Kirpnick Z, Homiski M, Rubitski E, et al. Yeast DEL assay detects clastogens. Mutat Res. 2005;582(1-2):116-134.
36. Sobol Z, Engel ME, Rubitski E, et al. Genotoxicity profiles of common alkyl halides and esters with alkylating activity. Mutat Res. 2007;633(2):80-94.
37. Galli A, Schiestl RH. Salmonella test positive and negative carcinogens show different effects on intrachromosomal recombination in G2 cell cycle arrested yeast cells. Carcinogenesis. 1995;16(3):659-663.
38. Galli A, Schiestl RH. Cell division transforms mutagenic lesions into deletion-recombinagenic lesions in yeast cells. Mutat Res. 1999;429(1):13-26.
39. Ku WW, Aubrecht J, Mauthe RJ, et al. Genetic Toxicity Assessment: Employing the Best Science for Human Safety Evaluation Part VII: Why Not Start with a Single Test: A Transformational Alternative to Genotoxicity Hazard and Risk Assessment. Toxicol Sci. 2007;99(1):20-25.
40. Bishop AJ, Schiestl RH. Homologous Recombination and Its Role in Carcinogenesis. JBiomed Biotechnol. 2002;2(2):75-85.
41. Hontzeas N, Hafer K, Schiestl RH. Development of a microtiter plate version of the yeast DEL assay amenable to high-throughput toxicity screening of chemical libraries. Mutat Res. 2007;634(1-2):228-234.
42. Fornace AJ, Jr., Alamo I, Jr., Hollander MC. DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA. 1988;85(23):8800-8804.
43. Holbrook NJ, Fornace AJ, Jr. Response to adversity: molecular control of gene activation following genotoxic stress. New Biol. 1991;3(9):825-833.
44. Amundson SA, Myers TG, Fornace AJ, Jr. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene. 1998;17(25):3287-3299.
45. Smith ML, Fornace AJ, Jr. Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis. Mutat Res. 1996;340(2-3):109-124.
46. Ben-Israel O, Ben-Israel H, Ulitzur S. Identification and quantification of toxic chemicals by use of Escherichia coli carrying lux genes fused to stress promoters. Appl Environ Microbiol. 1998;64(11):4346-4352.
47. Nunoshiba T, Nishioka H. Rec-lac test for detecting SOS-inducing activity of environmental genotoxic substance. Mutat Res. 1991;254(1):71-77.
48. Oda Y, Nakamura S, Oki I, et al. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat Res. 1985;147(5):219-229.
49. Ptitsyn LR, Horneck G, Komova O, et al. A biosensor for environmental genotoxin screening based on an SOS lux assay in recombinant Escherichia coli cells. Appl Environ Microbiol. 1997;63(11):4377-4384.
50. Quillardet P, Huisman O, DAri R, et al. The SOS chromotest: Direct assay of the expression of gene sfiA as a measure of genotoxicity of chemicals. Biochimie. 1982;64(8-9):797-801.
51. Vollmer AC. Genotoxic sensors. Methods Mol Biol. 1998;102:145-151.
52. Cahill PA, Knight AW, Billinton N, et al. The GreenScreen genotoxicity assay: A screening validation programme. Mutagenesis. 2004; 19(2):105-119.
53. Lichtenberg-Frate H, Schmitt M, Gellert G, et al. A yeast-based method for the detection of cyto and genotoxicity. Toxicol In Vitro. 2003;17(5-6):709-716.
54. Todd MD, Lin X, Stankowski LF, Jr., et al. Toxicity screening of a combinatorial library: Correlation of cytotoxicity and gene induction to compound structure. JBiomol Screen. 1999;4(5):259-268.
55. Duerksen-Hughes PJ, Yang J, Ozcan O. p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing. Environ Health Perspect. 1999;107(10):805-812.
56. Yang J, Duerksen-Hughes P. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis. 1998; 19(6): 1117-1125.
57. Ko LJ, Prives C. p53: Puzzle and paradigm. Genes Dev. 1996;10(9):1054-1072.
58. Linke SP, Clarkin KC, Di Leonardo A, et al. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 1996;10(8):934-947.
59. Lopes UG, Erhardt P, Yao R, et al. p53-dependent induction of apoptosis by prote-asome inhibitors. J Biol Chem. 1997;272(20):12893-12896.
60. van der Lelie D, Regniers L, Borremans B, et al. The VITOTOX test, an SOS bioluminescence Salmonella typhimurium test to measure genotoxicity kinetics; Mutat Res. 1997;389(2-3):279-290.
61. Plaper A, Jenko-Brinovec S, Premzl A, et al. Genotoxicity of trivalent chromium in bacterial cells. Possible effects on DNA topology. Chem Res Toxicol. 2002; 15(7):943-949.
62. Aubrecht J, Narla RK, Ghosh P, et al. Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes. Toxicol Appl Pharmacol. 1999;154(3):228-235.
63. Todd MD, Lee MJ, Williams JL, et al. The CAT-Tox (L) assay: A sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam Appl Toxicol. 1995;28(1):118-128.
64. Beard SE, Capaldi SR, Gee P. Stress responses to DNA damaging agents in the human colon carcinoma cell line, RKO. Mutat Res. 1996;371(1-2):1-13.
65. Hastwell PW, Chai LL, Roberts KJ, et al. High-specificity and high-sensitivity genotox-icity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat Res. 2006;607(2):160-175.